Cite

HARVARD Citation

    Gan, H. et al. (n.d.). ATIM-23. PRELIMINARY FINDINGS OF A PHASE I SAFETY AND BIOIMAGING TRIAL OF KB004 (IFABOTUZUMAB) IN PATIENTS WITH GLIOBLASTOMA. Neuro-oncology. p. vi6. [Online]. 
  
Back to record